Deals
Thermo Fisher Agrees to Acquire Affymetrix for $1.3 Billion
- Acquisition seen adding 10 cents a share to annual earnings
- $14-a-share price represents 52% premium to Friday's close
This article is for subscribers only.
Thermo Fisher Scientific Inc. agreed to acquire Affymetrix Inc. in a deal valued at about $1.3 billion, adding technology used by scientists and biologists to analyze specimens at the cellular and genetic level.
Thermo Fisher will pay $14 a share in cash, according to a statement. That represents a premium of about 52 percent to Affymetrix’s closing price Friday. The transaction, expected to be completed by the end of June, will add 10 cents a share to earnings in the first full year, the company said.